The CTDP1 gene is associated with a specific form of Charcot-Marie-Tooth disease (CMT4), a group of inherited disorders that affect the peripheral nerves. These nerves carry signals between the brain and muscles, enabling movements and sensations. Mutations in the CTDP1 gene can lead to a subtype of CMT known as CMT4, characterized by weakness and atrophy of the muscles, particularly in the feet and legs, often leading to difficulties in walking and a high-stepped gait.

To diagnose this condition, genetic testing for the CTDP1 gene can be crucial. In the UAE, DNA Labs offers a specialized genetic test to identify mutations in the CTDP1 gene that are related to CMT4. This test is vital for individuals showing symptoms of CMT4 or those with a family history of the disease, as it can provide a definitive diagnosis.

The cost of the CTDP1 gene test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The results from this test can inform patients and their healthcare providers about the genetic basis of their condition, guiding treatment decisions and helping to predict the course of the disease. Additionally, knowing one’s genetic status can be important for family planning and understanding the risk of passing the condition on to future generations.